chr2-3387645-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016030.6(TRAPPC12):c.22G>A(p.Glu8Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000841 in 1,544,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016030.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAPPC12 | ENST00000324266.10 | c.22G>A | p.Glu8Lys | missense_variant | 2/12 | 1 | NM_016030.6 | ENSP00000324318.5 | ||
TRAPPC12 | ENST00000382110.6 | c.22G>A | p.Glu8Lys | missense_variant | 2/12 | 2 | ENSP00000371544.2 | |||
TRAPPC12 | ENST00000482645.1 | n.183G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000134 AC: 2AN: 149632Hom.: 0 AF XY: 0.0000125 AC XY: 1AN XY: 80150
GnomAD4 exome AF: 0.00000790 AC: 11AN: 1392656Hom.: 0 Cov.: 30 AF XY: 0.00000729 AC XY: 5AN XY: 685788
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2024 | The c.22G>A (p.E8K) alteration is located in exon 2 (coding exon 1) of the TRAPPC12 gene. This alteration results from a G to A substitution at nucleotide position 22, causing the glutamic acid (E) at amino acid position 8 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at